Radiation Therapy for Dupuytren's Disease
(Dupuytren's Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a randomized study to determine whether radiation therapy reduces the risk of progression / recurrence of Dupuytren's disease / contracture.
Who Is on the Research Team?
Bruce McGibbon, MD
Principal Investigator
Yale University
Frank D Buono, PhD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for adults diagnosed with Dupuytren's disease or contracture who want to see if radiation can help prevent their condition from getting worse. Specific inclusion and exclusion criteria are not listed, so eligibility may depend on a doctor's assessment.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Radiation Therapy
Trial Overview
The study randomly assigns participants to receive either radiation therapy or standard care to find out if radiation helps stop Dupuytren's disease from progressing or coming back.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
early stage DD (no flexion contraction in affected hand) - randomized to Radiotherapy
Patients are receiving standard of care.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.